Theravance Biopharma Inc. (TBPH) is currently at $10.52, up $0.85 or 8.79%
--Would be highest close since Jan. 4, 2024, when it closed at $11.52
--On pace for largest percent increase since April 25, 2022, when it rose 9.39%
--Currently up six of the past seven days
--Currently up five consecutive days; up 24.64% over this period
--Longest winning streak since Nov. 11, 2024, when it rose for five straight trading days
--Best five day stretch since the five days ending Dec. 13, 2021, when it rose 28.43%
--Up 11.8% month-to-date; on pace for best month since Nov. 2024, when it rose 12.26%
--Up 11.8% year-to-date
--Down 75.28% from its all-time closing high of $42.56 on July 7, 2017
--Up 6.16% from 52 weeks ago (Jan. 26, 2024), when it closed at $9.91
--Would be a new 52-week closing high
--Up 37.34% from its 52-week closing low of $7.66 on Aug. 9, 2024
--Traded as high as $10.90; highest intraday level since Jan. 4, 2024, when it hit $11.71
--Up 12.72% at today's intraday high; largest intraday percent increase since Nov. 13, 2024, when it rose as much as 15.15%
All data as of 1:59:13 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 24, 2025 14:01 ET (19:01 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.